Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Colvin mentioned that there were tiny amounts of an NHS small pool heat-treated concentrate available around the middle of 1984.

Published on: 30 September, 2024

At the NETR Haemophilia Working Party, it was suggested that until a positive test for AIDS and/or a vaccine is developed the use of blood products should be avoided. However this did not lead to any change of policy at The Royal London.

Published on: 30 September, 2024

Dr Colvin clarified that the statement he made that "there is no reason to spurn commercial concentrate" implied that he did not recommend that they don't buy commercial concentrate at all.

Published on: 30 September, 2024

Dr Colvin stated in his oral evidence "if you had abandoned all surgery except for the most life-saving and the home treatment programme and if you had cut back on dosage...the consequences of the temporary withdrawal of all blood products in the way that Dr Galbraith perfectly understandably recommended was a probable."

Published on: 30 September, 2024

Dr Colvin reported that there were 41 patients infected with HIV, of which 31 had severe Haemophilia A, 9 had moderate/mild Haemophilia A and 1 had Haemophilia B. He recalled three children who were infected with HIV from their treatment and one partner of a patient who was infected.

Published on: 30 September, 2024

By the mid 1970s a number of doctors held the view that non-A non-B Hepatitis was a mild or benign disease, which rested centrally on assertion and/or wishful thinking rather than evidence.

Published on: 07 August, 2024

The publication of "Percutaneous Liver Biopsy and Chronic Liver Disease in Haemophiliacs" in The Lancet meant that clinicians could no longer rely on the absence of overt or acute signs of hepatitis as a reliable indicator that non-A non-B Hepatitis would not develop.

Published on: 07 August, 2024

Dr Colvin in his evidence described an unwillingness for established clinicians to accept that Factor 8 might be flawed: he called the attitude "wishful thinking".

Published on: 08 August, 2024

Dr Brian Colvin described in his oral evidence some clinicians' belief that Non-A Non-B Hepatitis was benign as "wishful thinking".

Published on: 27 September, 2024

Dr Brian Colvin confirmed that, by 1975, the haemophilia treating community was aware that there was at least a possibility of chronic liver disease in haemophilia.

Published on: 27 September, 2024

Dr Brian Colvin told the Inquiry he treated very small children with cryoprecipitate until the mid 1980s.

Published on: 27 September, 2024

Dr Brian Colvin told the Inquiry that around 1982-1983 he was using a significant quantity of commercial concentrate in the hospital due to shortfall in NHS concentrate.

Published on: 27 September, 2024

Dr Winter held that due to the shortage Shortfalls were covered by the use of commercial concentrate, and cryoprecipitate was in limited use only for mild haemophilia or von Willebrand disorder, or occasionally for a child or rarely treated adult.

Published on: 27 September, 2024

With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that patients diagnosed with moderate haemophilia may have also received commercial concentrates

Published on: 27 September, 2024

With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that patients diagnosed with mild haemophilia may have also received commercial concentrates, in instances where DDAVP was proving ineffective.

Published on: 27 September, 2024

With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that while children were prioritised for being treated with NHS products and that prophylactic treatment for children, there was a possibility that children received commercial concentrates too.

Published on: 27 September, 2024

With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that with regards to the treatment of children, the general practice was that children were not given concentrate unless they absolutely needed it.

Published on: 27 September, 2024

Dr Winter took the post as director at the Haemophilia Centre in Margate in December 1983.

Published on: 27 September, 2024

Dr Winter held that at the Haemophilia Centre in Margate that around the time of 1983, there was a serious lack of funding.

Published on: 27 September, 2024

Dr Winter explained that no one approached Tooting hospital to help address the issue of cryoprecipitate supplies.

Published on: 27 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2373
  • Page 2374
  • Page 2375
  • Page 2376
  • Current page 2377
  • Page 2378
  • Page 2379
  • Page 2380
  • Page 2381
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.